Please cite this article as: de la Torre Hernandez J M, Palop R L, Jimenez Mazuecos J M, Sáez P C, Gutierez-Barrios A, Pinar E, Cid B, Fernandez L, Camarero T G, Urbano-Carrillo C, Oteo Dominguez J F, Jimenez Diaz V A, Gomez Menchero A E, Fernández E G, Córdoba Soriano J G, Ocaranza R, Úcar E A, Roman K G S, Leal S, Cáceres G M, Linares Vicente J A, Ferre G F, Carrillo X, Rama Merchán J C, Costa C, Sanchis J, Fernandes R, Rodrigues A, Vegas Valle J M, Pereira H, de Prado A P. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study. J Geriatr Cardiol 2022; 19(5): 354−366. DOI: 10.11909/j.issn.1671-5411.2022.05.009.
Citation:
|
Please cite this article as: de la Torre Hernandez J M, Palop R L, Jimenez Mazuecos J M, Sáez P C, Gutierez-Barrios A, Pinar E, Cid B, Fernandez L, Camarero T G, Urbano-Carrillo C, Oteo Dominguez J F, Jimenez Diaz V A, Gomez Menchero A E, Fernández E G, Córdoba Soriano J G, Ocaranza R, Úcar E A, Roman K G S, Leal S, Cáceres G M, Linares Vicente J A, Ferre G F, Carrillo X, Rama Merchán J C, Costa C, Sanchis J, Fernandes R, Rodrigues A, Vegas Valle J M, Pereira H, de Prado A P. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study. J Geriatr Cardiol 2022; 19(5): 354−366. DOI: 10.11909/j.issn.1671-5411.2022.05.009.
|
Please cite this article as: de la Torre Hernandez J M, Palop R L, Jimenez Mazuecos J M, Sáez P C, Gutierez-Barrios A, Pinar E, Cid B, Fernandez L, Camarero T G, Urbano-Carrillo C, Oteo Dominguez J F, Jimenez Diaz V A, Gomez Menchero A E, Fernández E G, Córdoba Soriano J G, Ocaranza R, Úcar E A, Roman K G S, Leal S, Cáceres G M, Linares Vicente J A, Ferre G F, Carrillo X, Rama Merchán J C, Costa C, Sanchis J, Fernandes R, Rodrigues A, Vegas Valle J M, Pereira H, de Prado A P. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study. J Geriatr Cardiol 2022; 19(5): 354−366. DOI: 10.11909/j.issn.1671-5411.2022.05.009.
Citation:
|
Please cite this article as: de la Torre Hernandez J M, Palop R L, Jimenez Mazuecos J M, Sáez P C, Gutierez-Barrios A, Pinar E, Cid B, Fernandez L, Camarero T G, Urbano-Carrillo C, Oteo Dominguez J F, Jimenez Diaz V A, Gomez Menchero A E, Fernández E G, Córdoba Soriano J G, Ocaranza R, Úcar E A, Roman K G S, Leal S, Cáceres G M, Linares Vicente J A, Ferre G F, Carrillo X, Rama Merchán J C, Costa C, Sanchis J, Fernandes R, Rodrigues A, Vegas Valle J M, Pereira H, de Prado A P. Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study. J Geriatr Cardiol 2022; 19(5): 354−366. DOI: 10.11909/j.issn.1671-5411.2022.05.009.
|